Women's Health Issues
Volume 14, Issue 2 , Pages 51-59 , March 2004

Context of care and contraceptive method use

  • Lori A. Boardman, MD, ScM

      Affiliations

    • Division of Ambulatory Care, Department of Obstetrics and Gynecology, Women and Infants' Hospital, Providence, Rhode Island, USA
    • Corresponding Author InformationCorrespondence to: Lori Boardman, MD, ScM, Women and Infants' Hospital, 101 Dudley Street, Providence RI, USA 02905; Phone: 401-274-1122, ext. 2725; Fax: 401-453-7684.
    • ,
  • Sherry Weitzen, PhD

      Affiliations

    • Division of Research, Department of Obstetrics and Gynecology, Women and Infants' Hospital, Providence, Rhode Island, USA
    • ,
  • Kate L. Lapane, PhD

      Affiliations

    • Department of Community Health, Brown Medical School, and Center for Gerontology and Health Care Research, Brown University, Providence, Rhode Island, USA

Received 9 July 2003 ,Revised 7 October 2003 ,Accepted 2 March 2004.

References 

  1. Abma J, Chandra A, Mosher W, Peterson L, Piccinino L. Fertility, family planning, and women's health (New data from the 1995 National Survey of Family Growth). Vital Health and Statistics Series 23. 1997;19:1–114
  2. The Alan Guttmacher Institute . Uneven and Unequal (Insurance Coverage and Reproductive Health Services). New York: The Alan Guttmacher Institute; 1994;
  3. Baveja R, Buckshee K, Das K, Das SK, Hazra MN, Gopalan S, et al.  Evaluating contraceptive choice through the method-mix approach. An Indian Council of Medical Research (ICMR) task force study. Contraception. 2000;61:113–119
  4. Brown GF, Moskowitz EH. Moral and policy issues in long-acting contraception. Annual Review of Public Health. 1997;18:379–400
  5. Busen NH, Britt RB, Rianon N. Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years. Journal of Adolescent Health. 2003;32:257–259
  6. Chandra A. Surgical sterilization in the United States (Prevalence and characteristics, 1965–1995). Vital Health and Statistics Series 23. 1998;20:1–33
  7. Cromer BA. Bone mineral density in adolescent and young women on injectable or oral contraception. Current Opinion in Obstetrics and Gynecology. 2003;15:353–357
  8. Dailard C. Challenges facing family planning clinics and Title X. Issues in Brief. The Alan Guttmacher Institute. 2001;6:1–4
  9. Frank ML, Poindexter AN, Bateman L. Factors associated with the choice of Norplant by women attending subsidized clinics in the US. Advances in Contraception. 1993;9:161–174
  10. Fu H, Darroch JE, Haas T, Ranjit N. Contraceptive failure rates (New estimates from the 1995 National Survey of Family Growth). Family Planning Perspectives. 1999;31:56–63
  11. Hardee K, Balogh S, Villinski MT. Three countries' experience with Norplant. Introduction. Health Policy and Planning. 1997;12:199–213
  12. Harrison DD, Cooke CW. An elucidation of factors influencing physicians' willingness to perform elective female sterilization. Obstetrics and Gynecology. 1988;72:565–570
  13. Henshaw SK. Unintended pregnancy in the United States. Family Planning Perspectives. 1998;30:24–29
  14. Hosmer DW, Lemeshow S. In: Applied logistic regression. 2nd ed.. New York: John Wiley and Sons; 2002;
  15. Kaeser L. Public funding and policies for provision of the contraceptive implant, fiscal year 1992. Family Planning Perspectives. 1994;26:11–16
  16. Kurth, A., Bielinski, L., Graap, K., Conniff, J., & Connell, F. A. (2001). Reproductive and sexual health benefits in private health insurance plans in Washington State. Family Planning Perspectives, 33, 153–160, 179
  17. Malat J. Racial differences in Norplant use in the United States. Social Science and Medicine. 2000;50:1297–1308
  18. Mosher WD. Contraceptive practice in the United States (1982–1988). Family Planning Perspectives. 1990;22:198–205
  19. Mosher WD, Bachrach CA. Understanding US fertility (Continuity and change in the National Survey of Family Growth, 1988–1995). Family Planning Perspectives. 1996;28:4–12
  20. O'Dell CM, Forke CM, Polaneczky MM, Sondheimer SJ, Slap GB. Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents. Obstetrics and Gynecology. 1998;91:609–614
  21. Piccinino LJ, Mosher WD. Trends in contraceptive use in the United States (1982–1995). Family Planning Perspectives. 1998;30:4–10
  22. Potter F, Iannacchione V, Mosher W, Mason R, Kavee J. Sample design, sampling weights, imputation and variance estimation in the 1995 National Survey of Family Growth. Vital Health and Statistics Series 2. 1998;124:1–63
  23. Radecki SE, Bernstein GS. Use of clinic versus private family planning care by low-income women (Access, cost, and patient satisfaction). American Journal of Public Health. 1989;79:692–697
  24. Thompson MS. Contraceptive implants (Long acting and provider dependent contraception raises concerns about freedom of choice). British Medical Journal. 1996;313:1393–1395
  25. Westhoff C. Depot-medroxyprogesterone acetate injection (Depo-Provera) (A highly effective contraceptive option with proven long-term safety). Contraception. 2003;68:75–87

☆ Supported in part by National Institutes of Health grant K23 HD01307, Mentored Investigator Award in Women's Health from the National Institute of Child Health and Human Development.

PII: S1049-3867(04)00016-7

doi: 10.1016/j.whi.2004.03.002

Women's Health Issues
Volume 14, Issue 2 , Pages 51-59 , March 2004

Article Tools